Please do not fill-in this field

About
Our Work
Services & Facilities
People
Education
Careers
News & Events

Support COVID-19 Research

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

About
Our Work
- Institute Themes
- Immunology
- Antimicrobial Resistance
Services & Facilities
- Services
- Facilities
People
Education
Careers
News & Events

Support COVID-19 Research

News

08 Dec 2021

Trialling treatments for COVID-19

First published in the Doherty Institute Impact Report 2020

News Archive

2023
- January
- February
- March
- April
- May
- June
2022
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2021
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2020
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2019
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2018
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2017
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2016
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2015
- June
- July
- August
- October
- November
- December

KEEP INFORMED

Facebook
Twitter
Instagram

Subscribe for the latest news, events and research

For any media enquiries, please contact:

Communications Team
P: +61383441911
E: doherty-media@unimelb.edu.au

Contact Us

792 Elizabeth Street
Melbourne, 3000
Get Directions

doherty-reception@unimelb.edu.au
+61 3 9035 3555
Contact Us

Facebook
Twitter
Instagram
LinkedIn

Keep informed

Subscribe for the latest news, events and research

First name

Last name

We acknowledge the Wurundjeri people of the Kulin Nation as the traditional custodians of the land where our Institute stands.

We are committed to collaboration with Aboriginal and Torres Strait Islander communities to reduce the unacceptable burden of infectious disease. We are committed to training the next generation of exceptional Indigenous leaders in infection and immunity.